Navigation Links
DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
Date:1/14/2008

Company Accelerating Efforts to Commercialize Bio-Based Technologies to

Meet Growing Global Demand

WILMINGTON, Del., Jan. 14 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) has named Nicholas C. Fanandakis group vice president - DuPont Applied BioSciences. In this newly created position, Fanandakis will lead the company's accelerated efforts to commercialize a range of bio-based products and technologies to meet growing global demand.

DuPont Applied BioSciences includes the following businesses: BioFuels, BioMaterials, BioSpecialties and BioMedical.

"Renewable energy, renewably sourced materials and other bio-based technologies are in high demand by the industries we serve," said Executive Vice President and Chief Innovation Officer Thomas M. Connelly, Jr. "DuPont is in a strong leadership position with a robust pipeline of product candidates, many of which are the result of the focused application of our scientific capabilities beginning more than a decade ago. With three decades of business leadership experience, Nick will lead our accelerated charge to deliver these products to the global marketplace."

Fanandakis, 51, currently vice president of planning, previously served four years as vice president and general manager of DuPont Chemical Solutions Enterprise. He has held a range of business leadership roles since joining the company in 1979.

William J. Harvey, 57, currently vice president - Corporate Operations, will succeed Fanandakis as vice president of planning.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

(Bios and photos of Nicholas Fanandakis and William Harvey are available at http://www2.dupont.com/Our_Company/en_US/executives/index.html )


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. KGI Names Kerry Howell Vice President for Advancement
9. Vical Names Andrew de Guttadauro Vice President, Corporate Development
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Sciences today announced the three Winners and six Finalists of the 2017 Blavatnik ... annually by the Blavatnik Family Foundation and administered by the New York Academy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... genomics analysis platform specifically designed for life science researchers to analyze and ... researcher Rosalind Franklin, who made a major contribution to the discovery of ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia ... be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” ... pathology adoption best practices and how Proscia improves lab economics and realizes an ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):